Term Sheet

The latest on private equity, M&A, deals and movements — from Wall Street to Silicon Valley

Exclusive: New job for venture capitalist Akkaraju

February 28, 2013: 1:26 PM ET

akkarajuWest Coast healthcare investor finds a new home.

FORTUNE -- Healthcare-focused venture capitalist Srini Akkaraju is switching firms, Fortune has learned.

Akkaraju joined the Menlo Park, Calif. office of New Leaf Venture Partners in January 2009, where he has worked on biopharmaceutical deals like Synageva BioPharma (GEVA) and Intercept Pharmaceuticals (ICPT). Sources say that he recently accepted a position with Sofinnova Ventures, although not all of his transition details have been finalized with New Leaf (where he remains on the company's website).

A Sofinnova Ventures spokeswoman declined to comment, while Akkaraju did not respond to an email sent to his New Leaf account.

Before joining New Leaf, Akkaraju had been a co-founding partner of Panorama Capital -- a venture capital firm formed when J.P. Morgan (JPM) chose to spin out JPMorgan Partners into a pair of independent firms (Panorama focuses on VC, while the buyout team became CCMP Capital). Akkaraju also had been with JPMorgan Partners, and also was a business and corporate development executive with Genentech Inc.

Sign up for Dan's daily email newsletter on deals and deal-makers: GetTermSheet.com

Join the Conversation
About This Author
Dan Primack
Dan Primack
Senior Editor, Fortune

Dan Primack joined Fortune.com in September 2010 to cover deals and dealmakers, from Wall Street to Sand Hill Road. Previously, Dan was an editor-at-large with Thomson Reuters, where he launched both peHUB.com and the peHUB Wire email service. In a past journalistic life, Dan ran a community paper in Roxbury, Massachusetts. He currently lives just outside of Boston.

Email a Tip | @danprimack | RSS
Current Issue
  • Give the gift of Fortune
  • Get the Fortune app
  • Subscribe
Powered by WordPress.com VIP.